Applications Received for Device Pass-Through Status for CY 2026 We received eight complete applications by the March 3, 2025, quarterly deadline, which was the last quarterly deadline for applications to be received in time to be included in the CY 2026 OPPS/ASC proposed rule
There was only one genotyping failure with Sentosa SQ HCV Genotyping Assay and the results were 100% reproducible in our experience
Functional Markers: MMA and Homocysteine Serum B12 is not the only way to assess vitamin B12 status
The Long R3 modification prevents it from binding to IGF-binding proteins, allowing it to remain active in the body for a longer duration
Supports adrenal health, energy production from foods, and is beneficial for arthritis, allergies, acne, skin problems, and sexual endurance